Drug Approval | July 26, 2022
Lupin receives approval from U.S. FDA for Azilsartan Medoxomil Tablets
The product will be manufactured at Lupin's facility in Nagpur, India.
The product will be manufactured at Lupin's facility in Nagpur, India.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Merck’s first microbiology application and training lab in India
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
She joins Enveda from Gilead Sciences
Subscribe To Our Newsletter & Stay Updated
